NabilMAhmedMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor, Pediatric Hematology & Oncology, Baylor College of Medicine
Dr. Ahmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4890- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 2001 - 2003
Lincoln Medical and Mental Health CenterInternship, Transitional Year, 2000 - 2001
Cairo University School of MedicineClass of 1995
Certifications & Licensure
TX State Medical License 2006 - 2024
MI State Medical License 2006 - 2007
Clinical Trials
- Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma Start of enrollment: 2010 Feb 11
- CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM Start of enrollment: 2010 Oct 01
- Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsTandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Kh Chow, V...> ;The Journal of Clinical Investigation. 2021 Jul 1
- 2 citationsAuthor Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymomaLaura K. Donovan, Alberto Delaidelli, Sujith K. Joseph, Kevin Bielamowicz, Kristen Fousek, Borja L. Holgado, Alex Manno, Dilakshan Srikanthan, Ahmed Z. Gad, Randy Van ...> ;Nature Medicine. 2021 May 27
- 12 citationsA subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma.Vanaja Konduri, Sujith K. Joseph, Tiara T. Byrd, Zeid Nawas, Jonathan Vazquez-Perez, Colby J. Hofferek, Matthew M. Halpert, Dongliang Liu, Zhengdong Liang, Yunyu Baig,...> ;Science Translational Medicine. 2021 May 5
- Join now to see all
Journal Articles
- Retraction Note: A Homing System Targets Therapeutic T Cells to Brain CancerNabil Ahmed, Fong W Lam, Meenakshi Hegde, Jordan S Orange, Thomas Shum, Rakesh K Jain, Nature
Abstracts/Posters
- Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for ImmunotherapyNabil Ahmed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Other
- Evaluation and management of fever in children with non-chemotherapy-induced neutropeniaAhmed NM, Palazzi DL
http://www.uptodate.com/contents/evaluation-and-management-of-fever-in-children-with-non-chemotherap
UpToDate, Wolters Kluwer Health - 2013-01-02 - Risk of infection in children with fever and non-chemotherapy-induced neutropeniaAhmed NM, Palazzi DL
http://www.uptodate.com/contents/risk-of-infection-in-children-with-fever-and-non-chemotherapy-induc
UpToDate, Wolters Kluwer Health - 2013-04-16 - Fever in children with chemotherapy-induced neutropeniaAhmed NM, Flynn PM
http://www.uptodate.com/contents/fever-in-children-with-chemotherapy-induced-neutropenia
UpToDate, Wolters Kluwer Health - 2013-01-07
Press Mentions
- Africa Will Not Meet WHO’s 10% Vaccination Target by September: WHOAFROJune 10th, 2021
- There Are Vital Lessons to Learn from Africa’s Vaccination Rollout: WHO-AFROMay 4th, 2021
Baylor College of Medicine Secures $1.4m to Fund a CAR T Cell-Based Clinical Trial Investigating Advanced Sarcoma in ChildrenDecember 6th, 2020- Join now to see all
Hospital Affiliations
Texas Children's HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
